Brainstorm Cell Therapeutics

-$0.06 (-2.03%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCLI and other ETFs, options, and stocks.

About BCLI

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury.

CEO
Chaim Lebovits
Employees
43
Headquarters
New York, New York
Founded
2000

BCLI Key Statistics

Market cap
105.45M
Price-Earnings ratio
—
Dividend yield
—
Average volume
74.73K
High today
$3.06
Low today
$2.86
Open price
$2.91
Volume
116.06K
52 Week high
$4.46
52 Week low
$2.65

BCLI Earnings

-$0.43
-$0.33
-$0.23
-$0.13
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.13 per share
Actual
-$0.15 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure